An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis v...

书目详细资料
Main Authors:	André, P, Groettrup, M, Klenerman, P, de Giuli, R, Booth, B, Cerundolo, V, Bonneville, M, Jotereau, F, Zinkernagel, R, Lotteau, V
格式:	Journal article
语言:	English
出版:	1998

相似书籍

Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
由: Cerundolo, V, et al.
出版: (1998)

Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes.
由: Kelleher, A, et al.
出版: (2001)

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
由: Gileadi, U, et al.
出版: (1999)

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.
由: Klenerman, P, et al.
出版: (1998)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
由: Anjali K. Gupta, et al.
出版: (2007-04-01)

CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.
由: Milicic, A, et al.
出版: (2005)

Competitive Metabolite Profiling of Natural Products Reveals Subunit Specific Inhibitors of the 20S Proteasome
由: Atul Pawar, et al.
出版: (2020-01-01)

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
由: Valmori, D, et al.
出版: (1999)

Computational investigations of HIV-1 protease and protease inhibitors interactions
由: Sham, Hoi Fung
出版: (2014)

The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
由: Cerundolo, V, et al.
出版: (1997)

Current and Novel Inhibitors of HIV Protease
由: Jan Konvalinka, et al.
出版: (2009-12-01)

Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
由: Johanna Bialas, et al.
出版: (2015-01-01)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
由: Kourjian G, et al.
出版: (2012-09-01)

Additivity in the Analysis and Design of HIV Protease Inhibitors
由: Jorissen, Robert N., et al.
出版: (2012)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
由: V.B. Denisenko, et al.
出版: (2010-02-01)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
由: V.B. Denisenko, et al.
出版: (2010-02-01)

Proteasome inhibitors as anti-cancer agents.
由: Murray, R, et al.
出版: (2000)

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
由: Valmori, D, et al.
出版: (1999)

Down-regulation of Akt signaling with HIV-1 protease inhibitors
由: Gupta, A, et al.
出版: (2005)

Effects of an anticarcinogenic Bowman-Birk protease inhibitor on purified 20S proteasome and MCF-7 breast cancer cells.
由: Larissa da Costa Souza, et al.
出版: (2014-01-01)

New proteasome inhibitors in the management of multiple myeloma
由: S. V. Semochkin
出版: (2019-07-01)

MAPPING OF PATENTS RELATED TO PROTEASE INHIBITORS AND HIV
由: Romério Rodrigues dos Santos Silva, et al.
出版: (2022-04-01)

Role of Gag in HIV Resistance to Protease Inhibitors
由: Fabrizio Mammano, et al.
出版: (2010-07-01)

Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2
由: Roberta Rinaldi, et al.
出版: (2021-11-01)

TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation
由: Abhilash I. Chiramel, et al.
出版: (2019-06-01)

Site-Specific Proteasome Inhibitors
由: Alexei F. Kisselev
出版: (2021-12-01)

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
由: Noah M. Merin, et al.
出版: (2014-12-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
由: Christoph Driessen, et al.
出版: (2016-03-01)

Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity.
由: Hemelaar, J, et al.
出版: (2001)

The capture proteasome assay (CAPA) to evaluate subtype-specific proteasome inhibitors
由: Nathalie Vigneron, et al.
出版: (2015-09-01)

Evaluation of COVID-19 protease and HIV inhibitors interactions
由: Tran Linh, et al.
出版: (2022-03-01)

Safety of protease inhibitors in HIV-infected pregnant women
由: Chougrani I, et al.
出版: (2013-09-01)

Cardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).
由: Kathleen M S E Reyskens, et al.
出版: (2013-01-01)

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
由: Konvalinka Jan, et al.
出版: (2011-08-01)

Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study
由: Kann G, et al.
出版: (2021-08-01)

Immune surveillance and AIDS progression.
由: Zinkernagel, R, et al.
出版: (1997)

Correspondence - Immune surveillance and AIDS progression
由: Zinkernagel, R, et al.
出版: (1997)

Of mice and men: cytotoxic T cells and AIDS pathogenesis.
由: Klenerman, P, et al.
出版: (1999)

What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?
由: Klenerman, P, et al.
出版: (1997)

Resistance associated mutations to protease inhibitors on HIV-2 infected patients in Portugal
由: J. Lopes, et al.
出版: (2021-04-01)